Cargando…

Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?

This study examines how Chinese drug regulations are shifting illicit fentanyl production from China to India. This change has implications for the law, drug enforcement, pharmaceutical industry, and public health, as domestic production increases domestic access to fentanyl, in India. An empirical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Lassi, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614337/
https://www.ncbi.nlm.nih.gov/pubmed/36311594
http://dx.doi.org/10.3389/fpubh.2022.969395
_version_ 1784820178745294848
author Wang, Chao
Lassi, Nicholas
author_facet Wang, Chao
Lassi, Nicholas
author_sort Wang, Chao
collection PubMed
description This study examines how Chinese drug regulations are shifting illicit fentanyl production from China to India. This change has implications for the law, drug enforcement, pharmaceutical industry, and public health, as domestic production increases domestic access to fentanyl, in India. An empirical examination of current trends in fentanyl production and use in the region is conducted, along with an exegesis of the legal and regulatory systems in China and India. There is an accounting of the chemical and pharmaceutical industries, the strengths and weaknesses of drug legislation, and the public health consequences of increased production, distribution, and use of fentanyl in India. This study also details how the Indian government meets this challenge through legislative mechanisms, foremost through class-wide legislative control over fentanyl and its precursors. Class-wide control prohibits the unlawful production and distribution of all current and future fentanyl analogs and their precursors, disincentivizing and disrupting their development and production. The Indian government should also reduce domestic demand by promoting harm reduction measures such as opioid substitution therapy, evidence-based treatment, fentanyl test strip and naloxone distribution, and needle exchange programs.
format Online
Article
Text
id pubmed-9614337
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96143372022-10-29 Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? Wang, Chao Lassi, Nicholas Front Public Health Public Health This study examines how Chinese drug regulations are shifting illicit fentanyl production from China to India. This change has implications for the law, drug enforcement, pharmaceutical industry, and public health, as domestic production increases domestic access to fentanyl, in India. An empirical examination of current trends in fentanyl production and use in the region is conducted, along with an exegesis of the legal and regulatory systems in China and India. There is an accounting of the chemical and pharmaceutical industries, the strengths and weaknesses of drug legislation, and the public health consequences of increased production, distribution, and use of fentanyl in India. This study also details how the Indian government meets this challenge through legislative mechanisms, foremost through class-wide legislative control over fentanyl and its precursors. Class-wide control prohibits the unlawful production and distribution of all current and future fentanyl analogs and their precursors, disincentivizing and disrupting their development and production. The Indian government should also reduce domestic demand by promoting harm reduction measures such as opioid substitution therapy, evidence-based treatment, fentanyl test strip and naloxone distribution, and needle exchange programs. Frontiers Media S.A. 2022-10-14 /pmc/articles/PMC9614337/ /pubmed/36311594 http://dx.doi.org/10.3389/fpubh.2022.969395 Text en Copyright © 2022 Wang and Lassi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Wang, Chao
Lassi, Nicholas
Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
title Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
title_full Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
title_fullStr Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
title_full_unstemmed Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
title_short Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
title_sort combating illicit fentanyl: will increased chinese regulation generate a public health crisis in india?
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614337/
https://www.ncbi.nlm.nih.gov/pubmed/36311594
http://dx.doi.org/10.3389/fpubh.2022.969395
work_keys_str_mv AT wangchao combatingillicitfentanylwillincreasedchineseregulationgenerateapublichealthcrisisinindia
AT lassinicholas combatingillicitfentanylwillincreasedchineseregulationgenerateapublichealthcrisisinindia